The Effect of Anti-epileptic Drugs on Mitochondrial Activity
NCT01218321 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 60
Last updated 2018-03-06
Summary
This study is based on the hypothesis that antiepileptic drugs (other than Valproic acid) have an effect on the mitochondrial oxidative phosphorylation.
The objective of this study is to evaluate this effect in an accessible tissue-human peripheral white blood cells.
Conditions
Interventions
- BIOLOGICAL
-
antiepileptic treatment
White blood cells from peripheral blood samples
Sponsors & Collaborators
-
Hadassah Medical Organization
lead OTHER
Principal Investigators
-
Itai Berger, MD · Hadassah Medical Organization
Eligibility
- Min Age
- 3 Years
- Max Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2011-01-31
- Primary Completion
- 2011-12-31
- Completion
- 2012-06-30
Countries
- Israel
Study Locations
More Related Trials
-
Pharmacokinetic Study With an Oral Suspension of Perampanel as Adjunctive Therapy in Pediatric Subjects With Epilepsy
NCT02914314 ·Status: COMPLETED ·Phase: PHASE2
-
TAK-935 Multiple Rising Dose Study in Healthy Participants
NCT02539134 ·Status: COMPLETED ·Phase: PHASE1
-
Safety, Tolerability, and Exploratory Efficacy of Adjunctive EQU-001 for Seizures in Adults With Epilepsy
NCT05063877 ·Status: UNKNOWN ·Phase: PHASE2
-
Study to Evaluate Pharmacokinetics and Tolerability of Multiple Doses of Eslicarbazepine Acetate and Oxcarbazepine
NCT00900237 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Investigate How Effective, Safe and Tolerable the Drug NBI-921352 is When Used With Anti-seizure Medications in Adults With Focal Onset Seizures
NCT05159908 ·Status: COMPLETED ·Phase: PHASE2
-
Adherence to Pharmacological Antiepileptic Treatment in Adolescence
NCT05825807 ·Status: UNKNOWN
-
A Double-blind, Randomised, Placebo-controlled, Rising Multiple Dose Study to Investigate the Safety, Tolerability, Steady State Pharmacokinetic Profile and CNS Effects of BIA 2-093
NCT02171234 ·Status: COMPLETED ·Phase: PHASE1
-
A Single Centre, Phase I, Double-blind, Randomised, Placebo-controlled Study to Investigate the Safety, Tolerability, Pharmacokinetic Profile and Effects on EEG of Single Rising Oral Doses of BIA 2-093
NCT02171195 ·Status: COMPLETED ·Phase: PHASE1
-
Safety and Efficacy of Oxcarbazepine Monotherapy in Adults With Partial Seizures
NCT00275925 ·Status: COMPLETED ·Phase: PHASE4
-
Study to Test the Efficacy and Safety of Padsevonil as Adjunctive Treatment of Focal-onset Seizures in Adults With Drug-resistant Epilepsy
NCT03373383 ·Status: COMPLETED ·Phase: PHASE2
-
Adverse Event Scale in Patients With Epilepsy (aEscape) - A European Survey for Physicians With Epilepsy Patients
NCT00394927 ·Status: COMPLETED
-
A Study to Learn if Multiple Doses of the Study Medicine Called Carbamazepine Changes How the Body Processes the Other Study Medicine PF-07248144
NCT07198035 ·Status: COMPLETED ·Phase: PHASE1
-
Study to Evaluate the Safety and Effectiveness of USL255 in Patients With Refractory Partial-onset Seizures
NCT01142193 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Efficacy of Eslicarbazepine Acetate Monotherapy in Subjects With Partial Epilepsy Not Well Controlled by Current Antiepileptic Drugs
NCT00866775 ·Status: COMPLETED ·Phase: PHASE3
-
Enhancing Antiepileptic Drug Adherence
NCT02165306 ·Status: COMPLETED ·Phase: NA
-
GSK Drug Single Dose Escalation And Their Effect On Resting Motor Threshold In Healthy Volunteers
NCT00488566 ·Status: COMPLETED ·Phase: PHASE1
-
A Randomised, Double-blind, Placebo-controlled Phase 2a Pilot Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ONP-002 in Adults With Mild Traumatic Brain Injury
NCT06870240 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
A Study To Evaluate The Effect Of Topiramate On Clinical And Electrophysiological Parameters In Subjects With Diabetic Peripheral Polyneuropathy
NCT00231673 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Evaluate the Efficacy and Safety of Seletracetam in Adult Patients With Refractory Partial Onset Seizures
NCT00422110 ·Status: WITHDRAWN ·Phase: PHASE2/PHASE3
-
Pharmacokinetics and Safety of Intravenous Topiramate in Adult Patients
NCT00753493 ·Status: COMPLETED ·Phase: PHASE1
-
A Trial of Generic Substitution of Antiepileptic Drugs
NCT02429596 ·Status: UNKNOWN ·Phase: PHASE4
-
A Study of the Efficacy and Safety of Topiramate as add-on Therapy in the Treatment of Epilepsy Patients With Difficult to Treat, Partial-onset Seizures.
NCT00236691 ·Status: COMPLETED ·Phase: PHASE2
-
Premenstrual Dysphoric Disorder and Antiepileptic Drugs
NCT00612235 ·Status: COMPLETED
-
The Efficacy of a Subanesthetic Doses of IV Ketamine in the Treatment Drug Resistant Epilepsy
NCT05019885 ·Status: RECRUITING ·Phase: PHASE2
-
A Single-blind, Placebo-controlled, Outpatient Trial to Assess the Effects of Single Oral Tablet Dose of OPC-214870
NCT04241965 ·Status: COMPLETED ·Phase: PHASE1